Milestone Pharmaceuticals Inc (MIST) - כמות מזומנים למניה

Milestone Pharmaceuticals Inc - לוגו גרפי של המנפיק MIST

Milestone Pharmaceuticals (MIST) is developing an ecosystem of rapid-response solutions for tachycardia treatment via a nasal spray. Patent protection of the method ensures stable sales within emergency medicine. However, preparations for the product's market launch are depleting liquid reserves. The cash per share figure helps identify asset overheating in a timely manner, and 1.17 reflects the latest value of this metric.

Milestone Pharmaceuticals, Inc. (MIST): יתרות מזומנים למניה מ-04.07.2022 עד 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור milestonepharma.com (MIST)

- מדדי זמינות כספים ותזרימי מזומנים:
ניתוח מסכם של החברה:MIST Milestone Pharma
מוצר ממותג של Milestone Pharmaceuticals

This metric reflects the volume of liquid assets per common share, allowing for the real-time tracking of actual capital dynamics without the delays of quarterly reporting. By analyzing the cash position per share chart, an investor assesses the resource management efficiency of Milestone Pharmaceuticals (MIST), which is critical given the virtual drug development model and total reliance on external contract manufacturing.